Candel Therapeutics Inc. (CADL)
NASDAQ: CADL
· Real-Time Price · USD
6.05
0.01 (0.17%)
At close: Aug 15, 2025, 3:59 PM
6.10
0.74%
After-hours: Aug 15, 2025, 07:51 PM EDT
Candel Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 7.38M | -14.07M | -10.65M | -22.24M | -8.22M | -11.1M | -8.44M | -9.61M | -8.79M | -5.08M | -8.69M | -4.15M | -874K | 1.6M | -16.16M | -17.08M | -4.48M |
Depreciation & Amortization | 245K | 245K | 245K | 249K | 251K | 312K | 245K | 236K | 230K | 221K | 205K | 187K | 165K | 178K | 21K | 7K | 26K |
Stock-Based Compensation | 314K | 1.24M | 1.18M | 1.84M | 1.04M | 939K | 686K | 733K | 733K | 634K | 743K | 438K | 492K | -446K | 1.91M | 1.07M | 431K |
Other Working Capital | -2.33M | 799K | 984K | 480K | -1.73M | 1.43M | -844K | 1.49M | -2.64M | 473K | -937K | 822K | 926K | 1.4M | -1.11M | -29K | -1.8M |
Other Non-Cash Items | -14.73M | 6.03M | 1.8M | 13.51M | 1.67M | 2.22M | 170K | 163K | -492K | -2.59M | -199K | -4.81M | -8.18M | 18K | 19K | 19K | 20K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | -1.39M | -416K | -144K | n/a | n/a | n/a | n/a | n/a | -8.64M | 8.25M | 11.9M | n/a |
Change in Working Capital | -1.82M | 743K | 844K | 441K | -1.68M | 1.6M | -1.06M | 1.43M | -2.5M | -71K | -1.45M | 1.24M | 347K | 2.06M | -932K | -379K | -1.63M |
Operating Cash Flow | -8.62M | -5.81M | -6.57M | -6.2M | -8.44M | -7.42M | -8.81M | -7.2M | -10.82M | -6.88M | -9.38M | -7.1M | -8.05M | -5.24M | -6.89M | -4.46M | -5.63M |
Capital Expenditures | -3K | -3K | n/a | -6K | -7K | -47K | -103K | -169K | -138K | -276K | -215K | -635K | -171K | -504K | -392K | -710K | -229K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | 20K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | 20K | n/a | n/a | 157K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -3K | -3K | n/a | -6K | -7K | -27K | -103K | -169K | 19K | -276K | -215K | -635K | -171K | -504K | -392K | -710K | -229K |
Debt Repayment | -2.5M | -2.5M | -2.5M | -2.5M | -1.67M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 19.91M | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | -121K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 246K | 370K | 103K | 990K | 226K | -121K | n/a | n/a | n/a | 36K | n/a | 22K | 6K | 29K | 71.36M | 333K | 112K |
Financial Cash Flow | -1.87M | 91.91M | 1.68M | 1.95M | -1.25M | -121K | n/a | n/a | n/a | 36K | n/a | 22K | 19.92M | -58K | 71.36M | 333K | 112K |
Net Cash Flow | -10.49M | 86.1M | -4.63M | -4.26M | -9.7M | -7.57M | -8.91M | -7.36M | -10.8M | -7.13M | -9.6M | -7.71M | 11.69M | -5.74M | 64.07M | -4.84M | -5.74M |
Free Cash Flow | -8.62M | -5.82M | -6.57M | -6.2M | -8.45M | -7.47M | -8.91M | -7.36M | -10.96M | -7.16M | -9.6M | -7.73M | -8.22M | -5.74M | -7.29M | -5.17M | -5.86M |